Full Text View
Tabular View
Study Results
Related Studies
Efficacy and Safety of Dexlansoprazole and Lansoprazole on Healing of Erosive Esophagitis
This study has been completed.
Study NCT00251693   Information provided by Takeda Global Research & Development Center, Inc.
First Received: November 8, 2005   Last Updated: November 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Esophagitis, Reflux
Esophagitis, Peptic
Additional conditions recognized in this trial
Esophagitis
More general conditions related to this trial
Digestive System Diseases
Esophageal Diseases
Gastroenteritis
Gastrointestinal Diseases
Peptic Ulcer
Interventions listed in this trial
Dexlansoprazole MR
Lansoprazole
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Ulcer Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Takeda Global Research &Development Center, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services